Krystal Biotech
KRYS
KRYS
194 hedge funds and large institutions have $3.07B invested in Krystal Biotech in 2023 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 72 increasing their positions, 66 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
9% more repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 66
38% less funds holding in top 10
Funds holding in top 10: 8 → 5 (-3)
41% less call options, than puts
Call options by funds: $57.9M | Put options by funds: $97.6M
Holders
194
Holding in Top 10
5
Calls
$57.9M
Puts
$97.6M
Top Buyers
| 1 | +$47.6M | |
| 2 | +$43.5M | |
| 3 | +$29.9M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$27.8M |
| 5 |
State Street
Boston,
Massachusetts
|
+$25.5M |
Top Sellers
| 1 | -$84.7M | |
| 2 | -$38M | |
| 3 | -$33.5M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$30.2M |
| 5 |
Pictet Asset Management
Carouge,
Switzerland
|
-$22.4M |